Phosphodiesterase 7A1 is expressed in human CD4+ naïve T cells at higher levels than in CD4+ memory cells and is not required during their CD3/CD28-dependent activation

Cellular Immunology

Volumn 242, Issue 1, 2006, Pages 31-38

  Nueda, Arsenio ^a   García Roger, Nuria ^a   Domenech, Teresa ^a   Godessart, Nuria ^a   Cárdenas, Alvaro ^a   Santamaría Babi, Luis F ^a   Beleta, Jorge ^a  

^a Almirall SA ^*  (Spain)

Author keywords

Cellular activation; Cellular proliferation; Costimulation; Human; T lymphocytes

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45RA ANTIGEN; CYCLIC AMP PHOSPHODIESTERASE; MESSENGER RNA; PHOSPHODIESTERASE; PHOSPHODIESTERASE 7A1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; FLOW CYTOMETRY; IMMUNOREGULATION; LYMPHOID TISSUE; MEMORY CELL; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANTIGENS, CD28; ANTIGENS, CD3; BLOTTING, NORTHERN; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; FLOW CYTOMETRY; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; RNA, MESSENGER; T-LYMPHOCYTE SUBSETS;

EID: 33845445704     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2006.09.001     Document Type: Article

References (41)

1. Torphy T.J. Phosphodiesterase isozymes: molecular targets for novel antiasthma agents. Am. J. Respir. Crit. Care Med. 157 (1998) 351-370
2. Torphy T.J., and Page C. Phosphodiesterases: the journey towards therapeutics. Trends Pharmacol. Sci. 21 (2000) 157-159
3. Beavo J.A., and Reifsnyder D.H. Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol. Sci. 11 (1990) 150-155
4. Beavo J.A. cGMP inhibition of heart phosphodiesterase: is it clinically relevant?. J. Clin. Invest. 95 (1995) 445
5. Ichimura M., and Kase H. A new cyclic nucleotide phosphodiesterase isozyme expressed in the T-lymphocyte cell lines. Biochem. Biophys. Res. Commun. 193 (1993) 985-990
6. Michaeli T., Bloom T.J., Martins T., Loughney K., Ferguson K., Riggs M., Rodgers L., Beavo J.A., and Wigler M. Isolation and characterization of a previously undetected human cAMP phosphodiesterase by complementation of cAMP phosphodiesterase-deficient Saccharomyces cerevisiae. J. Biol. Chem. 268 (1993) 12925-12932
7. Hetman J.M., Soderling S.H., Glavas N.A., and Beavo J.A. Cloning and characterization of PDE7B, a cAMP-specific phosphodiesterase. Proc. Natl. Acad. Sci. USA 97 (2000) 472-476
8. Sasaki T., Kotera J., Yuasa K., and Omori K. Identification of human PDE7B, a cAMP-specific phosphodiesterase. Biochem. Biophys. Res. Commun. 271 (2000) 575-583
9. Saldou N., Obernolte R., Huber A., Baecker P.A., Wilhelm R., Alvarez R., Li B., Xia L., Callan O., Su C., Jarnagin K., and Shelton E.R. Comparison of recombinant human PDE4 isoforms: interaction with substrate and inhibitors. Cell. Signal. 10 (1998) 427-440
10. Han P., Zhu X X., and Michaeli T. Alternative splicing of the high affinity cAMP-specific phosphodiesterase [PDE7A] mRNA in human skeletal muscle and heart. J. Biol. Chem. 272 (1997) 16152-16157
11. F.W. Kluxen, B. Hentsch, Patent WO0162940, Merck patent GmBH.
12. Torras-Llort M., and Azorin F. Functional characterization of the human phosphodiesterase 7A1 promoter. Biochem. J. 373 (2003) 835-843
13. Bloom T.J., and Beavo J.A. Identification and tissue-specific expression of PDE7 phosphodiesterase splice variants. Proc. Natl. Acad. Sci. USA 93 (1996) 14188-14192
14. Fuhrmann M., Jahn H.U., Seybold J., Neurohr C., Barnes P.J., Hippenstiel S., Kraemer H.J., and Suttorp N. Identification and function of cyclic nucleotide phosphodiesterase isoenzymes in airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 20 (1999) 292-302
15. Gardner C., Robas N., Cawkill D., and Fidock M. Cloning and characterization of the human and mouse PDE7B, a novel cAMP-specific cyclic nucleotide phosphodiesterase. Biochem. Biophys. Res. Commun. 272 (2000) 186-192
16. Miro X., Perez-Torres S., Palacios J.M., Puigdomenech P., and Mengod G. Differential distribution of cAMP-specific phosphodiesterase 7A mRNA in rat brain and peripheral organs. Synapse 40 (2001) 201-214
17. Hoffmann R., Abdel'Al S., and Engels P. Differential distribution of rat PDE-7 mRNA in embryonic and adult rat brain. Cell Biochem. Biophys. 28 (1998) 103-113
18. Bloom T.J. Cyclic nucleotide phosphodiesterase isozymes expressed in mouse skeletal muscle. Can. J. Physiol. Pharmacol. 80 (2002) 1132-1135
19. Perez-Torres S., Cortes R., Tolnay M., Probst A., Palacios J.M., and Mengod G. Alterations on phosphodiesterase type 7 and 8 isozyme mRNA expression in Alzheimer's disease brains examined by in situ hybridization. Exp. Neurol. 182 (2003) 322-334
20. Lee R., Wolda S., Moon E., Esselstyn J., Hertel C., and Lerner A. PDE7A is expressed in human B-lymphocytes and is up-regulated by elevation of intracellular cAMP. Cell. Signall. 14 (2001) 277-284
21. Smith S.J., Brookes-Fazakerley S., Donnelly L.E., Barnes P.J., Barnette M.S., and Giembycz M.A. Ubiquitous expression of phosphodiesterase 7A in human proinflammatory and immune cells. Am. J. Physiol. Lung Cell Mol. Physiol. 284 (2003) L279-L289
22. Giembycz M.A., Corrigan C.J., Seybold J., Newton R., and Barnes P. Identification of cyclic AMP phosphodiesterase 3, 4, and 7 in human CD4+ and CD8+ T-lymphocytes: role in regulating proliferation and the biosynthesis of interleukin-2. Br. J. Pharmacol. 118 (1996) 1945-1958
23. Li L., Yee C., and Beavo J.A. CD3- and CD28-dependent induction of PDE7 is required for T cell activation. Science 283 (1999) 848-851
24. Glavas N., Ostenson C., Schaefer J.B., Vasta V., and Beavo J. T cell activation up-regulates cyclic nucleotide phosphodiesterases 8A1 and 7A3. Proc. Natl. Acad. Sci. USA 98 (2001) 6319-6324
25. Nakata A., Ogawa A.K., Sasaki T., Koyama N., Wada K., Kotera J., Kikkawa H., Omori K., and Kaminuma O. Potential role of phosphodiesterase 7 in human T cell function: comparative effects of two phosphodiesterase inhibitors. Clin. Exp. Immunol. 128 (2002) 460-466
26. Yang G., McIntyre K.W., Townsend R.M., Shen H.H., Pitts W.J., Dodd J.H., Nadler S.G., McKinnon M., and Watson A.J. Phosphodiesterase 7A-deficient mice have functional T cells. J. Immunol. 171 (2003) 6414-6120
27. E. Terricabras, V. Segarra, J. Alvarez-Builla, J.J. Vaquero, J.M. Mínguez, Almirall Prodesfarma S.A., Patent WO-2004065391.
28. Artursson P. Epithelial transport of drugs in cell culture. I: a model for studying the passive diffusion of drugs over intestinal absorptive [Caco-2] cells. J. Pharm. Sci. 79 (1990) 476-482
29. Hansen M.B., Nielsen S.E., and Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 119 (1989) 203-210
30. T. Brown, K. Mackey, Analysis of RNA by Northern and slot blot hybridization, in: F.M. Ausubel, R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, K. Struhl, Current Protocols in Molecular Biology, 1997, pp. 4.9.1-4.9.16.
31. Prince H.E., York J., and Jensen E.R. Phenotypic comparison of the three populations of human lymphocytes defined by CD45RO and CD45RA expression. Cell Immunol. 145 (1992) 254-262
32. Swain S.L., Croft M., Dubey C., Haynes L., Rogers P., Zhang X., and Bradley L.M. From naive to memory T cells. Immunol. Rev. 150 (1996) 143-167
33. Liu K., Li Y., Prabhu V., Young L., Becker K.G., Munson P.J., and Weng N.P. Augmentation in expression of activation-induced genes differentiates memory from naive CD4+ T cells and is a molecular mechanism for enhanced cellular response of memory CD4+ T cells. J. Immunol. 166 12 (2001) 7335-7344
34. Schwabe U., Miyake M., Ohga Y., and Daly J.W. 4-(3-Cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone (ZK 62711): a potent inhibitor of adenosine cyclic 3′,5′-monophosphate phosphodiesterases in homogenates and tissue slices from rat brain. Mol. Pharmacol. 12 6 (1976) 900-910
35. Houslay M.D., Schafer P., and Zhang K.Y. Drug Discov. Today 10 22 (2005) 1503-1519 Keynote review: phosphodiesterase-4 as a therapeutic target
36. Kanda N., and Watanabe S. Regulatory roles of adenylate cyclase and cyclic nucleotide phosphodiestarases 1 and 4 in interleukin-13 production by activated human T cells. Biochem. Pharmacol. 62 (2001) 495-507
37. Vig M., George A., Sen R., Durdik J., Rath S., and Bal V. Commitment of activated T cells to secondary responsiveness is enhanced by signals mediated by cAMP-dependent protein kinase A-I. Mol. Pharmacol. 62 (2002) 1471-1481
38. Essayan D.M., Huang S.K., Kagey-Sobotka A., and Lichtenstein L.M. Differential efficacy of lymphocyte- and monocyte-selective pretreatment with a type 4 phosphodiesterase inhibitor on antigen-driven proliferation and cytokine gene expression. J. Allergy Clin. Immunol. 99 (1997) 28-37
39. Smith S.J., Cieslinski L.B., Newton R., Donnelly L.E., Fenwick P.S., Nicholson A.G., Barnes P.J., Barnette M.S., and Giembycz M.A. Discovery of BRL 50481, a selective inhibitor of phosphodiesterase 7: in vitro studies in human monocytes, lung macrophages and CD8+ T-lymphocytes. Mol. Pharmacol. 66 6 (2004) 1679-1689
40. Schwartz J.H. The many dimensions of cAMP signaling. Proc. Natl. Acad. Sci. USA 98 (2001) 13482-13484
41. Jenkins M.K., Khoruts A., Ingulli E., Mueller D.L., McSorley S.J., Reinhardt R.L., Itano A., and Pape K.A. In vivo activation of antigen-specific CD4 T cells. Annu. Rev. Immunol. 19 (2001) 23-45